To determine outcomes of minor urological surgery in frail older adults. DESIGN: Retrospective cohort study. SETTING: U.S. nursing homes (NHs). PARTICIPANTS: NH residents aged 65 and older undergoing minor inpatient urological surgery (cystoscopy, bladder biopsy, transurethral resection of bladder tumor, prostate biopsy, transurethral resection of prostate, removal of ureteral obstruction, suprapubic tube placement) in the United States between 2004 and 2012 (N534,605). MEASUREMENTS: One-year mortality and changes in functional status before and after surgery using the Minimum Data Set Activity of Daily Living (MDS-ADL) summary scale. RESULTS: Overall 1-year mortality was 50%, and on average, residents had a 1.9-point worsening in their MDS-ADL score at 1 year, whereas the most highly functional residents (baseline quartile of MDS-ADL scores (0-12)) had a 4.7-point worsening in their MDS-ADL scores at 1 year. Functional decline in residents 1 year after surgery was associated with decline in function in the 6 months before surgery (adjusted hazard ratio (aH)52.39, 95% confidence interval (CI)52.29-2.49), emergency procedures (aHR51.37, 95% CI51.31-1.43), older age aHR51.17,, and baseline cognitive impairment (aHR51.15, 95% CI51.11-1.20). CONCLUSION: Despite the low complexity of minor urological procedures, NH residents experience high mortality and many demonstrate sustained functional decline up to 1-year postoperatively. J Am Geriatr Soc 66: 909-915, 2018. 
A lmost two-thirds of all urological surgery is performed in older adults. 1 The number of older individuals undergoing urological surgery will increase dramatically in the near future, because the older population is expected to double between 2010 and 2050. 2, 3 Nursing home (NH) residents represent the frailest of older individuals undergoing surgery, and they tend to have characteristics contributing to vulnerability, including older age, greater comorbidity, polypharmacy, cognitive deficits, limited social support, and poor functional status. 4 The benefits of surgery in the NH population, however minor that surgery may be, are uncertain, and the extent to which surgery extends life and promotes functionality is unknown.
Functional status is defined as everyday behaviors necessary to maintain daily life, such as the ability to walk, bathe, dress, get out of bed, and use the toilet. Poor functional status has been associated with poor quality of life, limited survival, and hospitalization and is a determinant of caregiver needs and healthcare costs. [5] [6] [7] In NH residents who have limited life expectancy -43% 1-year mortality in men and 32% 1-year mortality in women, 8 the goal of surgery is often to improve functionality in the final years of life, but the trajectory of functional status after common, minor urological surgery has not been investigated.
To better define the functional outcomes resulting from minor elective urological surgery in frail older adults, we performed a retrospective cohort study in NH residents undergoing inpatient cystoscopy, bladder biopsy, transurethral resection of a bladder tumor, transurethral resection of the prostate, prostate biopsy, removal of ureteral obstruction, and suprapubic tube placement using national Medicare claims linked to the Minimum Data Set for Nursing Homes (MDS-NH). We expected to find poor outcomes in terms of function and mortality 1 year after surgery despite the relatively "minor" nature of these surgical procedures. Findings from this study will provide a better understanding of the functional risks associated with these minor procedures in this growing and vulnerable population and will be instrumental in counseling individuals undergoing these procedures in the future to set realistic expectations.
METHODS

Subjects and Databases
We . NH residents were classified as long term and included in the cohort if they had completed at least 2 or more consecutive full or quarterly assessments more than 90 days apart during the 6 months before their procedure and had a NH length of stay at least 90 days after the procedure. Our institutional (University of California, San Francisco) review board approved this study.
Outcome Measures
Our primary outcome measures were functional status and mortality. Functional status was measured using the MDS Activities of Daily Living (MDS-ADL) score-a validated measure of function in the MDS that measures 7 domains: dressing, personal hygiene, toilet use, transfer, locomotion, bed mobility, and eating. Summary scores range from 0 (total independence in all 7 domains) to 28 (total dependence in all 7 domains), 9 and scores have been validated against other standardized measures of functional independence. 10, 11 We defined baseline function using the MDS-ADL summary score reported on the most recent assessment before surgery. Changes in functional status were defined as a change of 2 or more points in the MDS-ADL summary score in either direction; an increase of 2 or more points indicated a decline in functional status, and a decrease of 2 or more points indicated an improvement in functional status. Changes of less than 2 points on the MDS-ADL summary score indicated no change in functional status, consistent with existing literature. [12] [13] [14] MDS-ADL measurements were made in 3-month increments from 6 months before surgery to 12 months after surgery. Mortality was measured using the date of death information from the Medicare Denominator File.
Covariates
Demographic data on age, sex, race, and type of admission (elective vs emergency) were obtained from the Medicare Inpatient Files. Information on comorbidity was collected from the Medicare Inpatient Files and the MDS and used to calculate a Charlson Comorbidity Index score. 15 ADL decline at baseline was determined based on an increase of 2 of more points in MDS-ADL summary score in the 6 months before surgery, and ADL groups were determined at baseline based on quartiles.
Cognitive impairment was calculated using a combination of measures. An individual was determined to have cognitive impairment if he or she had a diagnosis of Alzheimer's disease or dementia in the Medicare Inpatient File or the MDS, a score of 3 or more on the MDS Cognitive Performance Scale (MDS-CPS) measured in the MDS 2.0 up to 2010, 16, 17 or a score of 7 or less on the Brief Interview for Mental Status measured in the MDS 3.0 starting in 2010. 18 
Statistical Analysis
We fit multivariable Cox regression models to estimate the hazard ratios for mortality 1 year after surgery and for functional decline in survivors 1 year after surgery. Both models were adjusted for the age (65-74, 75-84, 85), sex, race (white, black, other), admission status (elective vs emergency), ADL decline at baseline, MDS-ADL score at baseline (0-12, 13-17, 18-21, 22-28), cognitive impairment at baseline, Charlson score, and calendar year that the procedure was performed in.
Dynamic trends of MDS-ADL scores in 3-month increments from baseline were calculated by tabulating the proportion of subjects 3, 6, 9, and 12 months after surgery with increases of more than 2 points from baseline. To accommodate missing outcome data, we used multiple imputation to fill in missing ADL scores. To make the assumption of missing at random more plausible, imputation models also used age, sex, race, type of admission (elective vs emergency), and Charlson score. Results are presented as percentages in stacked bar graphs.
We used mixed-effects spline models to explore MDS-ADL functional trajectories before and after surgery. We chose the cubic spline model to represent the nonlinear nature of our data over time, allowing the data to fit separate curves for each segment of time. 19 This method allowed us to incorporate multiple measurements for each subject spanning from 6 months before surgery to 12 months after. More specifically, these were cubic spline models with knots placed at -1, 0, 3, 6, and 9 months, where 0 months represents baseline. Models included fixed and random effects for the coefficients of the spline, with each subject's measurements scattered around a subjectspecific smooth curve. Fixed effects included age, sex, race, and comorbidity, allowing for the population trajectory to shift based on baseline characteristics. Mortality was graphed using the Kaplan-Meier method to estimate cumulative 1-year mortality from the date of surgery.
To contextualize our findings, we compared the outcomes of mortality and functional trajectories of our NH resident cohort undergoing minor urological surgery with those of a propensity-matched cohort of NH residents not undergoing these procedures. These cohorts were matched based on age, sex, race, baseline MDS-ADL score, baseline cognitive impairment, and baseline Charlson score. Propensity matching was performed based on caliper matching without replacement (caliper width 0.2 standard deviations of the logit propensity) to derive a matched sample. 20 To ensure effectiveness of propensity score balancing, we compared standardized differences in each predictor before and after matching. Once an adequate level of matching was achieved, we assessed the association between the outcomes (mortality and functional status) and the predictor of NH residents undergoing and not undergoing minor urological surgery.
RESULTS
Resident characteristics
A total of 36,405 residents underwent minor urological surgery during the study period. Residents had a mean age of 81.5 6 7.4, 63.4% were male, and 81.2% were white (Table 1) . Mean MDS-ADL summary score before surgery was 17.4 6 7.2, reflective of a poorly functioning cohort, and 29.3% of subjects experienced decline in MDS-ADL score ( 2-point increase in MDS-ADL score) in the 6 months before surgery; 60.9% of residents demonstrated cognitive impairment at baseline.
Mortality
Mortality after the procedure was high-11.2% 1 month after surgery and 49.5% 12 months after surgery ( Figure 1A ). Survival analysis stratified according to quartile of baseline MDS-ADL score demonstrated that 1-year mortality was greater in subjects with greater functional impairment ( Figure 1B) . In multivariate analysis (Table 2) , many factors were associated with 1-year mortality, including older age (adjusted hazard ratio (aHR)51.65, 95% confidence interval (CI)51.58-1.72 for 85 vs 65-70), functional decline in the 6 months before baseline (aHR51.23, 95% CI51.19-1.26), worse baseline functional status (aHR51.14, 95% CI51.35-1.47 for MDS-ADL score 22-28 vs 0-12), worse Charlson score at baseline (aHR51.42, 95% CI51.34-1.50 for Charlson score 5 vs 0), and procedures that were performed emergently (aHR51.41, 95% CI51.36-1.47). Factors that were protective against 1-year mortality included female sex (aHR50.88, 95% CI50.85-0.91) and nonwhite race (aHR50.94, 95% CI50.90-0.98 for black; aHR50.83, 95% CI50.76-0.92 for other races). Cognitive impairment was not statistically significantly associated with 1-year mortality.
Functional status
MDS-ADL scores declined from 6 months before surgery to 12 months after ( Figure 1A The proportion of residents who experienced functional decline was greatest in the 3 months after surgery (29.8%), representing 39.2% of surviving residents (Supplemental Figure S1 ). The proportion of residents who died rose from 24.0% at 3 months to 49.5% at 12 months after surgery, and the proportion of residents who maintained functional status fell from 38.4% to 21.1% during the same period. Only 7.8% of residents demonstrated an improvement in functional status 3 months after surgery and 8.5% 12 months after surgery.
Multivariate analysis demonstrated that functional decline in the 6 months before surgery was the strongest predictor of functional decline in those who survived to 1 year after surgery (aHR52.39, 95% CI52.29-2.49) ( Table 3) . Other predictors of functional decline in survivors 1 year after surgery included older age (85 vs 65-74, aHR51.17, 95% CI51.11-1.23), female sex (aHR51.05, 95% CI51.01-1.10), procedures that were performed emergently (aHR51.37, 95% CI51.31-1.43), and baseline cognitive impairment (aHR51.15, 95% CI51.11-1.20). Charlson score did not statistically significantly affect the outcome.
Propensity-matched analysis
Mortality and functional outcomes of propensity-matched NH residents undergoing and not undergoing minor urological surgery are shown in Supplemental Figure S2 . Residents undergoing these procedures were more likely to die than those not undergoing these procedures, whereas functional trajectories were similar between cohorts.
DISCUSSION
Despite the relatively minor nature of the inpatient procedures examined, NH residents had high mortality (50%) and sustained functional decline in the year after surgery. Residents with better functional status at baseline experienced greater functional decline; predictors of this decline included older age, functional decline in the 6 months before surgery, procedures being performed on an emergency basis, and cognitive impairment at baseline. This is one of the first studies to evaluate long-term functional outcomes of minor surgery in NH residents. For reference, annual mortality in all NH residents is high-43% for men and 32% for women. 8 Prior research in NH residents undergoing a much larger surgery for colon cancer demonstrated cumulative 1-year mortality of 53% and an average worsening of 3.9 points in MDS-ADL score. 12 These results do not dramatically differ from our findings in residents undergoing procedures of presumedly much lower complexity and morbidity, with 50% 1-year mortality and an average of a 1.9-point in MDS-ADL scores in residents from all quartiles of MDS-ADL scores and a 4.7-point worsening in the best quartile. Previously, we published on functional outcomes related specifically to transurethral resection of the prostate surgery and found that the majority of individuals gained little if any improvement in functional status in the year after surgery.
14 Function is an important treatment outcome in older adults with limited life expectancy, with prior research showing that 74% of such individuals would forgo burdens of treatment (e.g., extended length of hospital stay, extensive testing, invasive interventions) if it resulted in an outcome of survival with severe functional impairment. 7 These findings underscore the importance of and potential for functional decline and mortality in NH residents undergoing any type of procedure, large or small, complex or minor, high or low risk.
Our study found that the magnitude of functional decline was highest in residents in the best quartile of baseline functional status (MDS-ADL score 0-12). This could represent "floor effects" related to the outcome measure, whereby the instrument itself has a lower limit to the data values that it can specifically discern. Individuals with better baseline function have more function to lose than their more poorly functioning counterparts, placing them at proportionally higher risk of functional decline. This finding highlights the importance of the potential long-term risks in more highly functioning NH residents.
To contextualize our findings, we compared 1-year mortality and functional outcomes of NH residents undergoing minor urological surgery with those of propensitymatched residents not undergoing this type of surgery. We found higher mortality and similar functional trajectories in the two groups. This comparison suggests two important implications; mortality in residents undergoing these procedures is higher than in the general NH population, and these procedures, which are often performed to improve functionality, may not be fulfilling their intended purpose in this regard. It is important to consider that the comparison group represents a heterogeneous population that is probably experiencing other nonurological medical and surgical problems that are not accounted for in these analyses.
This study should be interpreted with certain limitations in mind. First, based on the limitations of using Medicare claims data, we were limited in our understanding of the indications that contributed to each surgery. Further research investigating individual, physician, and system-based factors that influence surgical decision- making is this population is necessary to obtain better understanding of the factors behind this problem. Likewise, important data pertaining to quality of life are lacking in these analyses and may explain some of our findings. For example, if an individual experienced hematuria from a bladder tumor and underwent a transurethral resection of a bladder tumor to address this problem, the procedure might improve their quality of life but not necessarily their function or longevity. Furthermore, expected improvement in quality of life resulting from surgery may be a strong motivator to perform surgery, but there are no existing data to support or refute this claim. Second, it is important to understand that these data only considered NH residents undergoing the surgical procedures of interest and hence represent only the numerator and not the denominator of the entire population with similar diseases who did not undergo surgery. Furthermore, these findings represent an association, but not causation, between individuals undergoing minor urological surgery and postoperative function and mortality. Third, the high mortality in our population makes it difficult to assess survivors without a survivor bias, whereby those who did not die during the year after surgery may have been healthier than those who did, although this bias would only serve to underestimate our findings of functional decline in survivors and serve to strengthen the study.
Rates of death and functional decline after minor urological surgery are high in NH residents. This is important information to consider when balancing the risks and benefits of any surgical procedure, major or minor, in this vulnerable population. Initiatives aimed at improving surgical decision-making and improving functional recovery after surgery in this population are necessary to ensure the best use of surgery in the final years of life. 
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